Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213037-25-000008
Filing Date
2025-08-28
Accepted
2025-08-28 16:56:32
Documents
22
Effectiveness Date
2025-08-28

Document Format Files

Seq Description Document Type Size
1 S-8 crdf-20250828.htm S-8 216609
2 EX-5.1 crdf-ex5_1.htm EX-5.1 24083
3 EX-23.2 crdf-ex23_2.htm EX-23.2 3751
4 EX-99.1 crdf-ex99_1.htm EX-99.1 29552
5 EX-99.2 crdf-ex99_2.htm EX-99.2 32368
6 EX-FILING FEES crdf_exfilingfees.htm   iXBRL EX-FILING FEES 54623
7 GRAPHIC img98650091_0.jpg GRAPHIC 10280
8 GRAPHIC img98650091_1.jpg GRAPHIC 10280
9 GRAPHIC img98650091_2.jpg GRAPHIC 10280
10 GRAPHIC img98650091_3.jpg GRAPHIC 10280
11 GRAPHIC img98650091_4.jpg GRAPHIC 10280
12 GRAPHIC img229051243_0.jpg GRAPHIC 209459
  Complete submission text file 0001213037-25-000008.txt   852225

Data Files

Seq Description Document Type Size
24 EXTRACTED XBRL INSTANCE DOCUMENT crdf_exfilingfees_htm.xml XML 9047
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-289921 | Film No.: 251274403
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)